相似文献
1
S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.
Cancer Lett. 2009 Apr 18;276(2):171-9. doi: 10.1016/j.canlet.2008.11.025. Epub 2009 Jan 7.
2
Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.
Mol Cancer Res. 2008 Oct;6(10):1649-56. doi: 10.1158/1541-7786.MCR-07-2048.
3
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Mol Cancer. 2006 Dec 8;5:69. doi: 10.1186/1476-4598-5-69.
4
Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.
FASEB J. 2005 Oct;19(12):1646-56. doi: 10.1096/fj.05-3928com.
5
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
Arthritis Rheum. 2006 Mar;54(3):742-53. doi: 10.1002/art.21668.
6
Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1.
Biol Reprod. 2011 Mar;84(3):604-12. doi: 10.1095/biolreprod.110.084152. Epub 2010 Oct 27.
7
Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways.
Blood. 2008 Aug 15;112(4):1129-38. doi: 10.1182/blood-2007-11-125203. Epub 2008 Jun 9.
8
Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway.
Cell Physiol Biochem. 2018;49(5):1677-1693. doi: 10.1159/000493611. Epub 2018 Sep 19.
9
Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Cell Signal. 2014 Jul;26(7):1576-88. doi: 10.1016/j.cellsig.2014.03.029. Epub 2014 Apr 2.
10
S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor.
J Urol. 2009 Mar;181(3):1347-52. doi: 10.1016/j.juro.2008.10.140. Epub 2009 Jan 20.
引用本文的文献
1
Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.
J Transl Med. 2024 Oct 4;22(1):900. doi: 10.1186/s12967-024-05685-8.
2
S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720.
Cells. 2023 Mar 23;12(7):980. doi: 10.3390/cells12070980.
3
Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor.
Transl Cancer Res. 2022 Aug;11(8):2843-2857. doi: 10.21037/tcr-22-1847.
4
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.
Discov Oncol. 2021 Sep 20;12(1):33. doi: 10.1007/s12672-021-00430-9.
5
The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC.
Clin Transl Med. 2022 Feb;12(2):e695. doi: 10.1002/ctm2.695.
6
A Novel Radioimmune Tc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An and Study.
Front Immunol. 2021 Aug 18;12:660842. doi: 10.3389/fimmu.2021.660842. eCollection 2021.
7
Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance.
Mol Oncol. 2021 Dec;15(12):3256-3279. doi: 10.1002/1878-0261.13063. Epub 2021 Jul 29.
8
Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Medicine (Baltimore). 2020 May;99(19):e20183. doi: 10.1097/MD.0000000000020183.
9
Overexpression of cytoplasmic sphingosine 1-phosphate receptor 1 promotes cell cycle progression and migration in human esophageal squamous cell carcinoma.
Int J Clin Exp Pathol. 2017 Oct 1;10(10):10293-10303. eCollection 2017.
10
Roles of sphingosine-1-phosphate signaling in cancer.
Cancer Cell Int. 2019 Nov 14;19:295. doi: 10.1186/s12935-019-1014-8. eCollection 2019.
本文引用的文献
1
Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1312-8. doi: 10.1161/ATVBAHA.107.143735. Epub 2007 Apr 12.
2
S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells.
Biochem Biophys Res Commun. 2007 Apr 27;356(1):239-44. doi: 10.1016/j.bbrc.2007.02.112. Epub 2007 Feb 28.
3
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
J Biol Chem. 2007 Mar 23;282(12):9082-9. doi: 10.1074/jbc.M610318200. Epub 2007 Jan 21.
4
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.
Bioorg Med Chem. 2007 Jan 15;15(2):663-77. doi: 10.1016/j.bmc.2006.10.060. Epub 2006 Nov 1.
5
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
N Engl J Med. 2006 Sep 14;355(11):1124-40. doi: 10.1056/NEJMoa052643.
6
Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.
Biochem J. 2006 Sep 15;398(3):547-56. doi: 10.1042/BJ20060299.
7
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.
Cancer Cell. 2006 Mar;9(3):225-38. doi: 10.1016/j.ccr.2006.02.023.
8
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
Cancer Res. 2006 Jan 1;66(1):221-31. doi: 10.1158/0008-5472.CAN-05-2001.
9
Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.
J Surg Res. 2006 Jan;130(1):80-7. doi: 10.1016/j.jss.2005.08.004. Epub 2005 Sep 23.
10
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
J Clin Oncol. 2005 Oct 10;23(29):7312-21. doi: 10.1200/JCO.2005.01.2799. Epub 2005 Aug 29.
Zotero 插件